We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biological Coating Halts Bleeding on Contact

By HospiMedica International staff writers
Posted on 30 Jan 2012
A nanoscale biological coating halts bleeding nearly instantaneously, an advance that could dramatically reduce battlefield deaths.

Researchers at the Massachusetts Institute of Technology (MIT; Cambridge, USA) and Ferrosan Medical Devices (Ferrosan; Soeborg, Denmark) developed a nanoscale biological coating that consists of alternating layers of thrombin--a natural clotting protein--and tannic acid. More...
The combination yields a biological film containing large amounts of functional thrombin that when sprayed onto a material, such as a sponge, can be used as a battlefield dressing. A key advantage of the spray method is that it allows a large amount of thrombin to be packed into the sponges, coating even the interior fibers. Once sprayed, the sponges can be molded to fit the shape of any wound and subsequently be stored for months before use.

In laboratory tests conducted at Ferrosan using a porcine spleen bleeding model, the coated sponges were applied to wounds with light pressure (from a human thumb), for 60 seconds, and stopped the bleeding within that time frame; sponges lacking thrombin required at least 150 seconds to stop the bleeding. For comparison, a simple gauze patch, applied for 12 minutes (the length of the experiment), failed stop bleeding. The researchers have filed a patent application on the technology, as well as on similar sponges coated with the antibiotic vancomycin. They are now working on combining the blood-clotting and antibiotic activities in a single sponge. The study describing the technology and the test results was published on December 27, 2011, in the online edition of Advanced Materials.

“Now we have an alternative that could be used without applying a large amount of pressure and can conform to a variety of wounds, because the sponges are so malleable,” said lead author Anita Shukla, PhD, of MIT. “Both materials are already approved by the US Food and Drug Administration, which could help with the approval process for a commercialized version of the sponges.”

Traditional methods to halt bleeding at the battlefield, such as tourniquets, are not suitable for the neck and many other parts of the body, causing researchers to try alternative approaches, all of which have disadvantages. Fibrin dressings and glues have a short shelf life, can cause an adverse immune response, while zeolite powders are difficult to apply under windy conditions, and can cause severe burns. Another option is bandages made of chitosan, a derivative of the primary structural material of shellfish exoskeletons. Those bandages have had some success but can be difficult to mold to fit complex wounds.

Related Links:

Massachusetts Institute of Technology
Ferrosan Medical Devices




New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Medical Examination & Procedure Light
Vega 80
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Six-month FlexPulse IDE data show positive outcomes with Abbott’s TactiFlex Duo catheter, confirming safety and efficacy seen in the CE Mark study for complex AFib (photo courtesy of Abbott)

Dual-Energy Ablation and Conduction System Pacing Show Positive Early Outcomes

Atrial fibrillation and other arrhythmias are common in both hospitalized and ambulatory patients, often complicating hemodynamic stability, stroke prevention, and perioperative care. Within this context,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.